{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:24:16Z","timestamp":1794846256962,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T00:00:00Z","timestamp":1551052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T00:00:00Z","timestamp":1551052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ankylosing spondylitis (AS) is a common inflammatory autoimmune disease, characterized by pathological osteogenesis. Mesenchymal stem cells (MSCs), as the main source of osteoblasts, participate in bone remodeling not only through differentiation into osteoblasts but also through indirect regulation of osteoclastogenesis. Our previous study indicated that the stronger osteogenic differentiation of MSCs from AS patients (ASMSCs) involved in pathological osteogenesis. However, whether there is any abnormality in the regulation of osteoclastogenesis by ASMSCs remains unclear. In this study, ASMSCs or MSCs from healthy donors (HDMSCs) were co-cultured with CD14\u2009+\u2009monocytes in osteoclast induction medium. Our results demonstrated that ASMSCs exhibited a stronger capacity to inhibit osteoclastogenesis than HDMSCs. To explore underlying mechanisms, cytokine array assays were performed, showing that ASMSCs secreted more CXCL5 than HDMSCs, which was confirmed by enzyme-linked immunosorbent assays. Moreover, inhibition of osteoclastogenesis by ASMSCs was recovered by decreasing CXCL5. Besides, the inhibitory effect of CXCL5 on osteoclastogenesis was confirmed by exogenous addition. Bioinformatics analysis was applied to find the interaction between miR-4284 and CXCL5, which was verified by luciferase reporter assays. Furthermore, we used miR-4284 inhibitors or mimics to prove that the expression of CXCL5 was regulated by miR-4284. Further analysis showed that downregulation of miR-4284 in MSCs resulted in increase of CXCL5, markedly inhibiting osteoclastogenesis, whereas upregulation of miR-4284 in MSCs had the opposite effect. Our findings indicate that ASMSCs exhibit a stronger capacity to inhibit osteoclastogenesis than HDMSCs through the miR-4284\/CXCL5 axis, which provide a new perspective on the mechanism of pathologic osteogenesis in AS.<\/jats:p>","DOI":"10.1038\/s41419-019-1448-x","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T10:03:44Z","timestamp":1551089024000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Abnormal inhibition of osteoclastogenesis by mesenchymal stem cells through the miR-4284\/CXCL5 axis in ankylosing spondylitis"],"prefix":"10.1038","volume":"10","author":[{"given":"Wenjie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinteng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuizhong","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su\u2019an","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiwen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,25]]},"reference":[{"key":"1448_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","volume":"390","author":"J Sieper","year":"2017","unstructured":"Sieper, J. & Poddubnyy, D. Axial spondyloarthritis. Lancet 390, 73\u201384 (2017).","journal-title":"Lancet"},{"key":"1448_CR2","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/art.24763","volume":"60","author":"ML DeLay","year":"2009","unstructured":"DeLay, M. L. et al. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum. 60, 2633\u20132643 (2009).","journal-title":"Arthritis Rheum."},{"key":"1448_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-014-0489-6","volume":"15","author":"JA Smith","year":"2015","unstructured":"Smith, J. A. Update on ankylosing spondylitis: current concepts in pathogenesis. Curr. Allergy Asthma Rep. 15, 489 (2015).","journal-title":"Curr. Allergy Asthma Rep."},{"key":"1448_CR4","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun, J. & Sieper, J. Ankylosing spondylitis. Lancet 369, 1379\u20131390 (2007).","journal-title":"Lancet"},{"key":"1448_CR5","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1056\/NEJMra1406182","volume":"374","author":"JD Taurog","year":"2016","unstructured":"Taurog, J. D., Chhabra, A. & Colbert, R. A. Ankylosing spondylitis and axial spondyloarthritis. N. Engl. J. Med. 374, 2563\u20132574 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1448_CR6","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.stem.2016.02.015","volume":"18","author":"R Yue","year":"2016","unstructured":"Yue, R., Zhou, B. O., Shimada, I. S., Zhao, Z. & Morrison, S. J. Leptin receptor promotes adipogenesis and reduces osteogenesis by regulating mesenchymal stromal cells in adult bone marrow. Cell Stem Cell 18, 782\u2013796 (2016).","journal-title":"Cell Stem Cell"},{"key":"1448_CR7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/art.39433","volume":"68","author":"Z Xie","year":"2016","unstructured":"Xie, Z. et al. Imbalance between bone morphogenetic protein 2 and noggin induces abnormal osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis. Arthritis Rheum. 68, 430\u2013440 (2016).","journal-title":"Arthritis Rheum."},{"key":"1448_CR8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1172\/JCI70050","volume":"124","author":"JL Crane","year":"2014","unstructured":"Crane, J. L. & Cao, X. Bone marrow mesenchymal stem cells and TGF-beta signaling in bone remodeling. J. Clin. Invest. 124, 466\u2013472 (2014).","journal-title":"J. Clin. Invest."},{"key":"1448_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-pathol-011110-130203","volume":"6","author":"X Feng","year":"2011","unstructured":"Feng, X. & McDonald, J. M. Disorders of bone remodeling. Annu. Rev. Pathol. 6, 121\u2013145 (2011).","journal-title":"Annu. Rev. Pathol."},{"key":"1448_CR10","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1016\/j.transproceed.2011.09.020","volume":"43","author":"SD Li","year":"2011","unstructured":"Li, S. D., Zhai, Q. L. & Qiu, L. G. Imbalance between bone formation and resorption in hematopoietic stem\/progenitor cells mobilization. Transplant. Proc. 43, 3920\u20133926 (2011).","journal-title":"Transplant. Proc."},{"key":"1448_CR11","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/art.30309","volume":"63","author":"K Oshita","year":"2011","unstructured":"Oshita, K. et al. Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production. Arthritis Rheum. 63, 1658\u20131667 (2011).","journal-title":"Arthritis Rheum."},{"key":"1448_CR12","doi-asserted-by":"publisher","first-page":"e72831","DOI":"10.1371\/journal.pone.0072831","volume":"8","author":"A Varin","year":"2013","unstructured":"Varin, A., Pontikoglou, C., Labat, E., Deschaseaux, F. & Sensebe, L. CD200R\/CD200 inhibits osteoclastogenesis: new mechanism of osteoclast control by mesenchymal stem cells in human. PLoS ONE 8, e72831 (2013).","journal-title":"PLoS ONE"},{"key":"1448_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1365-2141.1999.01491.x","volume":"106","author":"HM Massey","year":"1999","unstructured":"Massey, H. M. & Flanagan, A. M. Human osteoclasts derive from CD14-positive monocytes. Br. J. Haematol. 106, 167\u2013170 (1999).","journal-title":"Br. J. Haematol."},{"key":"1448_CR14","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1152\/physrev.00036.2016","volume":"97","author":"K Okamoto","year":"2017","unstructured":"Okamoto, K. et al. Osteoimmunology: the conceptual framework unifying the immune and skeletal systems. Physiol. Rev. 97, 1295\u20131349 (2017).","journal-title":"Physiol. Rev."},{"key":"1448_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle, W. J., Simonet, W. S. & Lacey, D. L. Osteoclast differentiation and activation. Nature 423, 337\u2013342 (2003).","journal-title":"Nature"},{"key":"1448_CR16","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrrheum.2009.217","volume":"5","author":"H Takayanagi","year":"2009","unstructured":"Takayanagi, H. Osteoimmunology and the effects of the immune system on bone. Nat. Rev. Rheumatol. 5, 667\u2013676 (2009).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1448_CR17","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1074\/jbc.M510156200","volume":"281","author":"MS Kim","year":"2006","unstructured":"Kim, M. S. et al. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption. J. Biol. Chem. 281, 1274\u20131285 (2006).","journal-title":"J. Biol. Chem."},{"key":"1448_CR18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/art.38286","volume":"66","author":"HR Kim","year":"2014","unstructured":"Kim, H. R. et al. Reciprocal activation of CD4+T cells and synovial fibroblasts by stromal cell-derived factor 1 promotes RANKL expression and osteoclastogenesis in rheumatoid arthritis. Arthritis Rheum. 66, 538\u2013548 (2014).","journal-title":"Arthritis Rheum."},{"key":"1448_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.immuni.2010.07.009","volume":"33","author":"J Mei","year":"2010","unstructured":"Mei, J. et al. CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection. Immunity 33, 106\u2013117 (2010).","journal-title":"Immunity"},{"key":"1448_CR20","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1002\/art.38750","volume":"66","author":"K Yoshida","year":"2014","unstructured":"Yoshida, K. et al. Citrullination of epithelial neutrophil-activating peptide 78\/CXCL5 results in conversion from a non-monocyte-recruiting chemokine to a monocyte-recruiting chemokine. Arthritis Rheum. 66, 2716\u20132727 (2014).","journal-title":"Arthritis Rheum."},{"key":"1448_CR21","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1172\/JCI72030","volume":"124","author":"G Nouailles","year":"2014","unstructured":"Nouailles, G. et al. CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis. J. Clin. Invest. 124, 1268\u20131282 (2014).","journal-title":"J. Clin. Invest."},{"key":"1448_CR22","doi-asserted-by":"publisher","first-page":"e3325","DOI":"10.1097\/MD.0000000000003325","volume":"95","author":"Z Li","year":"2016","unstructured":"Li, Z., Wong, S. H., Shen, J., Chan, M. T. & Wu, W. K. The role of MicroRNAS in ankylosing spondylitis. Medicine (Baltim.) 95, e3325 (2016).","journal-title":"Medicine (Baltim.)"},{"key":"1448_CR23","doi-asserted-by":"publisher","first-page":"i92","DOI":"10.1136\/ard.2010.140152","volume":"70","author":"J Wittmann","year":"2011","unstructured":"Wittmann, J. & Jack, H. M. microRNAs in rheumatoid arthritis: midget RNAs with a giant impact. Ann. Rheum. Dis. 70, i92\u2013i96 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"1448_CR24","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/hmg\/ddy008","volume":"27","author":"C Perez-Sanchez","year":"2018","unstructured":"Perez-Sanchez, C. et al. Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients. Hum. Mol. Genet. 27, 875\u2013890 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"1448_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden, S., Valkenburg, H. A. & Cats, A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 27, 361\u2013368 (1984).","journal-title":"Arthritis Rheum."},{"key":"1448_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00109-016-1489-x","volume":"95","author":"Z Xie","year":"2017","unstructured":"Xie, Z. et al. MCP1 triggers monocyte dysfunctions during abnormal osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis. J. Mol. Med. (Berl.) 95, 143\u2013154 (2017).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"1448_CR27","doi-asserted-by":"publisher","first-page":"913050","DOI":"10.1155\/2014\/913050","volume":"2014","author":"Y Li","year":"2014","unstructured":"Li, Y. et al. Whole genome expression profiling and signal pathway screening of MSCs in ankylosing spondylitis. Stem Cells Int. 2014, 913050 (2014).","journal-title":"Stem Cells Int."},{"key":"1448_CR28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.0105-2896.2009.00857.x","volume":"233","author":"NC Walsh","year":"2010","unstructured":"Walsh, N. C. & Gravallese, E. M. Bone remodeling in rheumatic disease: a question of balance. Immunol. Rev. 233, 301\u2013312 (2010).","journal-title":"Immunol. Rev."},{"key":"1448_CR29","first-page":"5","volume":"4","author":"IP Perpetuo","year":"2017","unstructured":"Perpetuo, I. P. et al. Ankylosing Spondylitis patients have impaired osteoclast gene expression in circulating osteoclast precursors. Front. Med. (Lausanne) 4, 5 (2017).","journal-title":"Front. Med. (Lausanne)"},{"key":"1448_CR30","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1210\/endo.140.8.6880","volume":"140","author":"G Mbalaviele","year":"1999","unstructured":"Mbalaviele, G. et al. Human mesenchymal stem cells promote human osteoclast differentiation from CD34+bone marrow hematopoietic progenitors. Endocrinology 140, 3736\u20133743 (1999).","journal-title":"Endocrinology"},{"key":"1448_CR31","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s10439-009-9638-9","volume":"37","author":"J Liu","year":"2009","unstructured":"Liu, J. et al. Pressure-loaded MSCs during early osteodifferentiation promote osteoclastogenesis by increase of RANKL\/OPG ratio. Ann. Biomed. Eng. 37, 794\u2013802 (2009).","journal-title":"Ann. Biomed. Eng."},{"key":"1448_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nrrheum.2015.162","volume":"12","author":"R Vicente","year":"2016","unstructured":"Vicente, R., Noel, D., Pers, Y. M., Apparailly, F. & Jorgensen, C. Deregulation and therapeutic potential of microRNAs in arthritic diseases. Nat. Rev. Rheumatol. 12, 211\u2013220 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1448_CR33","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1634\/stemcells.2007-0625","volume":"26","author":"U Lakshmipathy","year":"2008","unstructured":"Lakshmipathy, U. & Hart, R. P. Concise review: MicroRNA expression in multipotent mesenchymal stromal cells. Stem Cells 26, 356\u2013363 (2008).","journal-title":"Stem Cells"},{"key":"1448_CR34","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/stem.1623","volume":"32","author":"EA Clark","year":"2014","unstructured":"Clark, E. A., Kalomoiris, S., Nolta, J. A. & Fierro, F. A. Concise review: microrna function in multipotent mesenchymal stromal cells. Stem Cells 32, 1074\u20131082 (2014).","journal-title":"Stem Cells"},{"key":"1448_CR35","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/cdd.2015.168","volume":"23","author":"Q Chen","year":"2016","unstructured":"Chen, Q. et al. Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differ. 23, 1128\u20131139 (2016).","journal-title":"Cell Death Differ."},{"key":"1448_CR36","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1097\/MIB.0000000000000339","volume":"21","author":"G Koukos","year":"2015","unstructured":"Koukos, G. et al. A microRNA signature in pediatric ulcerative colitis: deregulation of the miR-4284\/CXCL5 pathway in the intestinal epithelium. Inflamm. Bowel Dis. 21, 996\u20131005 (2015).","journal-title":"Inflamm. Bowel Dis."},{"key":"1448_CR37","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.1002\/jcp.26500","volume":"233","author":"H Mohammadi","year":"2018","unstructured":"Mohammadi, H. et al. MicroRNA implications in the etiopathogenesis of ankylosing spondylitis. J. Cell Physiol. 233, 5564\u20135573 (2018).","journal-title":"J. Cell Physiol."},{"key":"1448_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/cei.12089","volume":"173","author":"NS Lai","year":"2013","unstructured":"Lai, N. S. et al. Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis. Clin. Exp. Immunol. 173, 47\u201357 (2013).","journal-title":"Clin. Exp. Immunol."},{"key":"1448_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3892\/mmr.2015.4494","volume":"13","author":"Y Jiang","year":"2016","unstructured":"Jiang, Y. & Wang, L. Role of histone deacetylase 3 in ankylosing spondylitis via negative feedback loop with microRNA-130a and enhancement of tumor necrosis factor-1alpha expression in peripheral blood mononuclear cells. Mol. Med. Rep. 13, 35\u201340 (2016).","journal-title":"Mol. Med. Rep."},{"key":"1448_CR40","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1159\/000480211","volume":"42","author":"Y Wang","year":"2017","unstructured":"Wang, Y., Luo, J., Wang, X., Yang, B. & Cui, L. MicroRNA-199a-5p induced autophagy and inhibits the pathogenesis of ankylosing spondylitis by modulating the mTOR signaling via directly targeting ras homolog enriched in Brain (Rheb). Cell Physiol. Biochem. 42, 2481\u20132491 (2017).","journal-title":"Cell Physiol. Biochem."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1448-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1448-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1448-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T16:36:22Z","timestamp":1671208582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1448-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,25]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["1448"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-1448-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,25]]},"assertion":[{"value":"14 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"188"}}